ELIZABETH KVALE to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications ELIZABETH KVALE has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.073
-
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015 May; 175(5):691-700.
Score: 0.073
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.